Science Explorer Interactive view Map
Topic · Genetics

Chronic Lymphocytic Leukemia Research

Chronic Lymphocytic Leukemia Research is a research topic within Genetics. Science Explorer counts 54k research works in it since 1950. 13.9% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the genomic aberrations, treatment strategies, and prognostic factors associated with chronic lymphocytic leukemia (CLL). It covers topics such as the use of BTK inhibitors (e.g., Ibrutinib), the role of rituximab, TP53 mutations, and the impact of immunoglobulin mutations. Additionally, it explores therapeutic targets and outcomes in patients with Waldenström macroglobulinemia.

  • Chronic Lymphocytic Leukemia
  • Genomic Aberrations
  • BTK Inhibitors
  • Rituximab
  • Ibrutinib
  • Prognostic Factors
  • TP53 Mutation
  • Waldenström Macroglobulinemia
  • Immunoglobulin Mutation
  • Therapeutic Targets
Research works
54k
fractional, since 1950
In the world top 10%
7.5k
per year above
Top-10% rate
13.9%
share of its works in the world top 10%
Growth, 2013–17 → 2018–22
+17%
the tick is no change

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Chronic Lymphocytic Leukemia Research research?

By volume, the United States and China publish the most (2.9k and 1.1k works in 2022–2025).

By volume, 2022–2025

  1. 1 United States 2.9k works
  2. 2 China 1.1k works
  3. 3 Italy 517 works
  4. 4 France 388 works
  5. 5 India 372 works
  6. 6 Japan 369 works
  7. 7 United Kingdom 360 works
  8. 8 Germany 346 works
  9. 9 Brazil 338 works
  10. 10 Spain 312 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 41.4%China: 15.8%Italy: 7.4%France: 5.5%6 others listed: 29.8%41%largest
United States2,915 · 41.4%China1,114 · 15.8%Italy517 · 7.4%France388 · 5.5%6 others listed2,097 · 29.8%

Shares of the rows listed above, not of the whole node.

Which institutions lead Chronic Lymphocytic Leukemia Research research?

By volume in 2022–2025, The University of Texas MD Anderson Cancer Center publishes the most Chronic Lymphocytic Leukemia Research research, followed by Dana-Farber Cancer Institute and Memorial Sloan Kettering Cancer Center.

By volume, 2022–2025

  1. 1 The University of Texas MD Anderson Cancer CenterUnited States 182 works
  2. 2 Dana-Farber Cancer InstituteUnited States 68 works
  3. 3 Memorial Sloan Kettering Cancer CenterUnited States 53 works
  4. 4 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 48 works
  5. 5 Mayo Clinic in ArizonaUnited States 42 works
  6. 6 The Ohio State UniversityUnited States 41 works
  7. 7 Moffitt Cancer CenterUnited States 37 works
  8. 8 Harvard UniversityUnited States 37 works
  9. 9 Mayo ClinicUnited States 35 works
  10. 10 Cleveland ClinicUnited States 34 works

Who are the leading researchers in Chronic Lymphocytic Leukemia Research?

The most-cited researchers publishing on Chronic Lymphocytic Leukemia Research include Kenneth J. Livak, Giuseppe Remuzzi and Gad Getz.

  1. 1 Kenneth J. Livak United States 20k citations
  2. 2 Giuseppe Remuzzi Italy 8.1k citations
  3. 3 Gad Getz United States 6.2k citations
  4. 4 Winfried März Germany 5.2k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

Where is Chronic Lymphocytic Leukemia Research research done?

The largest centres of Chronic Lymphocytic Leukemia Research research in 2022–2025 are Houston (United States), Beijing (China), New York (United States) and Boston (United States). Among places with at least 20 works in it, it is an unusually large share of all research in Duarte, North Chicago and Lancaster.

Largest cities, 2022–2025

  1. 1 Houston United States 220 works
  2. 2 Beijing China 198 works
  3. 3 New York United States 187 works
  4. 4 Boston United States 156 works
  5. 5 Paris France 136 works
  6. 6 São Paulo Brazil 112 works
  7. 7 London United Kingdom 112 works
  8. 8 Shanghai China 95 works
  9. 9 Rome Italy 94 works
  10. 10 Tokyo Japan 93 works

Where it is the local speciality

  1. DuarteUS · 22.1 works43×
  2. North ChicagoUS · 25.5 works31×
  3. LancasterUS · 22.0 works30×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Chronic Lymphocytic Leukemia Research than the world average.

See Chronic Lymphocytic Leukemia Research on the map

Where is the best place to study Chronic Lymphocytic Leukemia Research?

Among universities, judged by research, Vita-Salute San Raffaele University, Medical University of Lodz and Medical College of Wisconsin score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 17.76%fractional works in this node (log) →share in the world top 10% →Vita-Salute San Raffaele University: 16, 18.5%Medical University of Lodz: 12, 32.5%Medical College of Wisconsin: 17, 12.1%China Pharmaceutical University: 11, 21.9%Weill Cornell Medicine: 12, 13.1%Kettering University: 10, 13.4%Chinese Academy of Medical Sciences & Peking Union Medical College: 48, 11.8%King Saud University: 12, 21.7%Medical University of Lublin: 16, 9.9%Harvard University: 37, 22.7%Medical University o…China Pharmaceutical…Vita-Salute San Raff…Medical College of W…
above the meannear itbelow it

One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.

#UniversityScoreTop 10%SpecialisationWorksGrowth
1 Vita-Salute San Raffaele UniversityItaly 51.918.5%13.9×16 +26.6%
2 Medical University of LodzPoland 50.232.5%8.4×12 -16.5%
3 Medical College of WisconsinUnited States 46.812.1%7.2×17 +221.9%
4 China Pharmaceutical UniversityChina 46.021.9%5.4×11 +288.6%
5 Weill Cornell MedicineUnited States 44.713.1%9.6×12 —
6 Kettering UniversityUnited States 44.413.4%30.9×10 +44.2%
7 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 43.011.8%5.4×48 +103.1%
8 King Saud UniversitySaudi Arabia 43.021.7%1.5×12 +257.2%
9 Medical University of LublinPoland 42.89.9%10.8×16 +43.3%
10 Harvard UniversityUnited States 40.622.7%3.2×37 -0.3%

Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.

Is Chronic Lymphocytic Leukemia Research research growing?

Output in 2018–2022 was 17% higher than in 2013–2017, peaking in 2023. The fastest-growing topics are Chronic Lymphocytic Leukemia Research.

19801990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.